✦ LIBER ✦

Predictive role of multiple gene alterations in response to cetuximab in metastatic colorectal cancer: A single center study

✍ Scribed by Paola Ulivi, Laura Capelli, Martina Valgiusti, Wainer Zoli, Emanuela Scarpi, Elisa Chiadini, Paola Rosetti, Sara Bravaccini, Daniele Calistri, Luca Saragoni, Andrea Casadei Gardini, Angela Ragazzini, Giovanni Luca Frassineti, Dino Amadori, Alessandro Passardi

Book ID: 119905332
Publisher: BioMed Central
Year: 2012
Tongue: English
Weight: 214 KB
Volume: 10
Category: Article
ISSN: 1479-5876
DOI: 10.1186/1479-5876-10-87

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Tumour gene expression predicts response

Tumour gene expression predicts response to cetuximab in patients with KRAS wild-type metastatic colorectal cancer

✍ Baker, J B; Dutta, D; Watson, D; Maddala, T; Munneke, B M; Shak, S; Rowinsky, E 📂 Article 📅 2011 🏛 Nature Publishing Group 🌐 English ⚖ 640 KB

KRAS Mutation Status Is Predictive of Re

KRAS Mutation Status Is Predictive of Response to Cetuximab Therapy in Colorectal Cancer

✍ Lievre, A. 📂 Article 📅 2006 🏛 American Association for Cancer Research 🌐 English ⚖ 215 KB

6105 Single nucleotide polymorphisms in

6105 Single nucleotide polymorphisms in the vascular endothelial growth factor A gene predicts response to chemotherapy in patients with metastatic colorectal cancer

✍ Hansen, T.; Spindler, K.L.G.; Andersen, R.F.; Lindebjerg, J.; Brandslund, I.; Ja 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 45 KB

PP 39 Multi-determinants analysis of mol

PP 39 Multi-determinants analysis of molecular alterations as predictor of resistance to cetuximab in metastatic colorectal cancer

✍ P. Ulivi; A. Passardi; L. Capelli; E. Chiadini; S. Bravaccini; M. Valgiusti; E. 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 71 KB

A gene expression predictor of response

A gene expression predictor of response to EGFR-targeted therapy stratifies progression-free survival to cetuximab in KRAS wild-type metastatic colorectal cancer

✍ Justin M Balko; Esther P Black 📂 Article 📅 2009 🏛 BioMed Central 🌐 English ⚖ 657 KB

A Phase II Study of Cetuximab/Irinotecan

A Phase II Study of Cetuximab/Irinotecan in Patients with Heavily Pretreated Metastatic Colorectal Cancer: Predictive Value of Early Specific Toxicities

✍ Teresa Gamucci; Fabrizio Nelli; Giovanni Cianci; Giulia Grassi; Luca Moscetti; I 📂 Article 📅 2008 🏛 CIG Media Group, LP. 🌐 English ⚖ 114 KB